দেশ: নিউ জিলণ্ড
ভাষা: ইংরেজি
সূত্র: Ministry for Primary Industries
clostridium haemolyticum toxoid/cells; clostridium chauvoei toxoid/cells; clostridium perfringens type c toxoid; clostridium perfringens type b toxoid/cells; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium novyi type b toxoid/cells; clostridium perfringens type a toxoid; clostridium septicum toxoid; clostridium sordellii toxoid
Schering-Plough Animal Health Limited
clostridium perfringens type c toxoid, clostridium perfringens type d toxoid, clostridium perfringens type a toxoid, clostridium
clostridium haemolyticum toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium perfringens type c toxoid 0 vaccine; clostridium perfringens type b toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium perfringens type a toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium sordellii toxoid 0 vaccine
Vaccine
ACVM Registered
2002-09-26
COVEXIN 10 100 mL / 500 mL – Leaflet, Carton and Label A009028 Page 1 of 8 COVEXIN 10 01-Sep-23 Leaflet WARNING KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY COVEXIN ® 10 10-in-1 Clostridial Vaccine 100 ML (50 DOSES*) 500 ML (250 DOSES*) READ ENTIRE LEAFLET BEFORE USE. COVEXIN 10 contains toxoids of _Clostridium perfringens_ (types A, B, C and D), _C. novyi _(type B), _C. septicum, C. tetani,_ _C. sordellii,_ and _C. haemolyticum_ and whole cell culture of _C. chauvoei_. COVEXIN 10 also contains potash alum adjuvant and 0.015% w/v thiomersal. INDICATIONS For the active immunisation of sheep and cattle from 2 weeks of age against diseases caused by _Clostridium perfringens_ type A (enterotoxaemia, gas gangrene, sudden death syndrome), _C. _ _perfringens_ type B (lamb dysentery, enterotoxaemia), _C. perfringens_ type C (enterotoxaemia, struck), _C. perfringens_ type D (enterotoxaemia, pulpy kidney), C. _chauvoei_ (black leg, black quarter, post parturient gangrene), _C._ _novyi _type B (black disease, infectious necrotic hepatitis), _C_. _septicum_ (malignant oedema, braxy), _C._ _tetani_ (tetanus), _C. sordellii_ (sudden death syndrome), and _C. haemolyticum_ (red water disease). Full protection develops within 14 days of administration of the second dose. Duration of immunity is approximately 12 months from initial vaccination. Studies show that revaccination every 12 months is adequate to generate and maintain immunity. Where high levels of challenge are anticipated, more frequent booster vaccination may need to be considered. EQUIPMENT_ _ • Use sharp needles. • Change needles frequently (every 12 to 20 animals). • Needles and vaccinator guns should be sterile before starting. Needles can be sterilised by boiling for 10 minutes and storing in methylated spirits. ASSEMBLY OF VAXIPAK ® AND DRAW-OFF SET_ _ 1. Attach end of draw-off tube to the vaccinator gun. 2. Pierce centre of rubber stopper of Vaxipak with draw-off needle, ensuring that plastic overcap snaps into position on the Vaxipak cap. সম্পূর্ণ নথি পড়ুন